Discover open access scientific publications

Search, annotate, share and cite publications

Publications by U. Stosiek

Adjuvant Hormonotherapy (Tamoxifen Versus Medro-Xyprogesterone Acetate Versus Control) in Women With Endometrial Cancer, Figo Stage I and II

Journal of Cancer Research and Clinical Oncology

English

Related publications

(P042) the Impact of Adjuvant Management on Survival Endpoints in Women With Stage I Type II Endometrial Carcinoma

International Journal of Radiation Oncology Biology Physics

English

A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer

Breast Cancer Research

Cancer Research

Oncology

2013

English

Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-Ii Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis

Cancer Research and Treatment

Cancer Research

Oncology

2014

English

Validated Competing Event Model for the Stage I-Ii Endometrial Cancer Population

International Journal of Radiation Oncology Biology Physics

English

A Nested Case–control Study of Adjuvant Hormonal Therapy Persistence and Compliance, and Early Breast Cancer Recurrence in Women With Stage I–III Breast Cancer

British Journal of Cancer

Cancer Research

Oncology

2013

English

Utilization of Adjuvant Therapies and Their Impact on Survival for Women With Stage IIIc Endometrial Adenocarcinoma

International Journal of Radiation Oncology Biology Physics

English

Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer

English

Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation

English

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by U. Stosiek

Adjuvant Hormonotherapy (Tamoxifen Versus Medro-Xyprogesterone Acetate Versus Control) in Women With Endometrial Cancer, Figo Stage I and II

Related publications

(P042) the Impact of Adjuvant Management on Survival Endpoints in Women With Stage I Type II Endometrial Carcinoma

A Randomized Phase II Presurgical Trial of Weekly Low-Dose Tamoxifen Versus Raloxifene Versus Placebo in Premenopausal Women With Estrogen Receptor-Positive Breast Cancer

Postoperative Radiotherapy Alone Versus Chemoradiotherapy in Stage I-Ii Endometrial Carcinoma: An Investigational and Propensity Score Matching Analysis

Validated Competing Event Model for the Stage I-Ii Endometrial Cancer Population

A Nested Case–control Study of Adjuvant Hormonal Therapy Persistence and Compliance, and Early Breast Cancer Recurrence in Women With Stage I–III Breast Cancer

Utilization of Adjuvant Therapies and Their Impact on Survival for Women With Stage IIIc Endometrial Adenocarcinoma

Efficacy of First-Line Letrozole Versus Tamoxifen as a Function of Age in Postmenopausal Women With Advanced Breast Cancer

Adjuvant Treatment for Gastric Cancer: Chemotherapy Versus Radiation

Adjuvant Therapy in Stage II Colon Cancer: Current Approaches